Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Identifying and Characterizing Psoriasis and Psoriatic Arthritis Patients in Ontario Administrative Data: A
Lihi Eder1, Jessica Widdifield2, Cheryl F Rosen3
1L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto, and Women's College Research Institute, Women's College Hospital, Toronto; lihi.eder@wchospital.ca.
Objectives:
We assessed the accuracy of case definition algorithms for psoriasis and psoriatic arthritis (PsA) in health administrative data and used primary care electronic medical records (EMR) to describe disease and treatment characteristics of these patients.
Methods:
We randomly sampled 30,424 adult Ontario residents from the Electronic Medical Record Primary Care database and identified 2215 patients with any possible psoriatic disease-related terms in their EMR. The relevant patient records were chart abstracted to confirm diagnoses of psoriasis or PsA. This validation set was then linked to health administrative data to assess the performance of different algorithms for physician billing diagnosis codes, hospitalization diagnosis codes, and medications for psoriatic disease. We report the performance of selected case definition algorithms and describe the disease characteristics of the validation set.
Results:
Our reference standard identified 1028 patients with psoriasis and 77 patients with PsA, for an overall prevalence of 3.4% for psoriasis and 0.3% for PsA. Most patients with PsA (66%) had a rheumatology-confirmed diagnosis, while only 30% of the patients with psoriasis had dermatology-confirmed diagnosis. The use of systemic medications was much more common with PsA than with psoriasis. All algorithms had excellent specificity (97-100%). The sensitivity and positive predictive value were moderate and varied between different algorithms (34-72%).
Conclusion:
The accuracy of case definition algorithms for psoriasis and PsA varies widely. However, selected algorithms produced population prevalence estimates that were within the expected ranges, suggesting that they may be useful for future research purposes.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

